Gene Fragment Design for Reliable Assembly: A Pre-Order Checklist

Before ordering gene fragments, check two things separately: whether the exact sequence is suitable for synthesis, and whether the delivered fragment will fit your downstream assembly workflow. A fragment can meet its synthesis specifications yet still fail to produce the intended construct because its junctions, orientation, or vector context were designed incorrectly.

The most useful pre-order review starts with the final construct, works backward to the fragment sequences, and records what the supplier needs to evaluate. Compatibility depends on more than the insert sequence alone.

Create an annotated reference sequence for the construct you want after assembly. Use it to check:

·       The order and orientation of every insert.

·       The exact sequence at each insert–insert and insert–vector junction.

·       The coding frame across tags, linkers, and fusion boundaries.

·       Whether start and stop codons are required, already supplied by the vector, or intentionally omitted.

·       Which regulatory elements are supplied by the backbone and which must be included in the insert.

·       Any bases that must remain unchanged for the experiment.

Keep this final-construct reference separate from the sequences submitted for synthesis. Assembly overlaps may appear in two input fragments but only once in the assembled construct. Restriction sites and flanking bases may be removed during cloning.

Simulate the intended assembly and compare the resulting sequence with the reference. This provides a direct way to detect duplicated overlaps, missing bases, reversed inserts, and unintended junction sequences before ordering.

Evaluate the complete fragment, including assembly handles—not just its biological payload.

Design feature	What to check	What to clarify before ordering
Total length	Count every base, including overlaps, restriction sites, spacers, tags, and other flanking elements.	The supported delivered-fragment length for the exact sequence and requested format.
GC composition	Check overall GC content and local GC-rich or GC-poor regions.	Whether particular regions require redesign or a different synthesis approach.
Repeats and homopolymers	Identify tandem repeats, repeated modules, and runs of a single nucleotide.	Which features must remain unchanged and whether the supplier can accept them.
Predicted secondary structure	Flag inverted repeats and sequences predicted to form strong structures.	Whether these features affect acceptance or require additional review.
Sequence identity	Confirm fragment IDs, orientation, version, and exact bases.	How ambiguous bases or intentionally variable positions should be submitted.

Sequence complexity is a feasibility flag, not an automatic reason to reject a design.  Those are provider-specific considerations—not verified Dynegene acceptance thresholds.

Do not apply a universal GC cutoff or assume that splitting a sequence will solve every difficulty. Record the problematic region and ask for assessment of the exact design.

For coding sequences, synonymous changes may help address complexity while preserving the amino acid sequence, but they do not preserve the original nucleotide sequence. Obtain approval before changing any sequence whose nucleotide identity matters, including regulatory regions and experimentally defined variants.

Do Not Confuse Oligo Length With Delivered Fragment Length

Dynegene’s Gene Fragments product page describes a microarray synthesis platform and lists a maximum length per oligo. That figure is not a specification for the maximum length of a delivered gene fragment. The page does not establish a delivered-fragment length range or comprehensive sequence-acceptance limits; confirm these with the technical team for your project.

Choose the assembly method before finalizing fragment boundaries. Synthesis design concerns making the requested DNA; downstream assembly design concerns joining that DNA into the intended construct.

Overlap-Based Assembly

For Gibson Assembly or another overlap-based method:

·       Design overlaps between the actual adjacent sequences, including the linearized vector ends.

·       Check that overlaps direct the intended order and orientation.

·       Review repeated sequences that could create alternative annealing partners.

·       Specify whether overlaps will be included in the synthesized fragments or added in a separate preparation step.

·       Follow the instructions for the selected reagent system rather than treating one overlap length as universal.

Golden Gate Assembly

For Golden Gate Assembly, record the selected Type IIS enzyme and map the recognition sites, cleavage positions, and resulting overhangs for every part and the destination vector.

Check for internal sites recognized by that enzyme. If a site must be removed, document the proposed sequence change and verify that it is acceptable for the experiment. Also assess the complete overhang set: different overhang sequences do not necessarily have equal ligation fidelity.

Inspect the predicted final junctions rather than assuming that the assembly will automatically be scarless or preserve the coding frame.

Restriction–Ligation Cloning

For conventional restriction cloning, verify that the intended sites are present at the correct boundaries and that unwanted internal sites will not disrupt the insert. Check the selected enzyme’s requirements for cleavage near a DNA end; a recognition site placed directly at the fragment terminus may not be sufficient for efficient digestion.

A vector name alone is not enough to define an assembly junction. Laboratory stocks may differ from a published map or have been modified during earlier experiments.

Prepare:

·       The exact backbone sequence or an annotated vector file.

·       The insertion coordinates and insert orientation.

·       The planned linearization method and resulting end sequences.

·       Any tag, linker, start codon, or stop codon supplied by the vector.

·       The expected final construct sequence.

If the backbone sequence or insertion boundary is uncertain, resolve that uncertainty before approving the fragment design. A synthesis review cannot compensate for an incorrect vector reference.

Also state who will perform assembly. Ordering linear fragments for in-house cloning is a different request from ordering an assembled, sequence-verified plasmid. Define the required deliverable explicitly rather than relying on labels such as “full-length” or “cloning-ready.”

Use the following checklist as a project record and inquiry attachment. It is a preparation template, not a statement of Dynegene’s mandatory submission requirements.

Check	Information to prepare
☐ Project identity	Project name, sequence version, date, and technical contact.
☐ Required deliverable	Linear fragments or an assembled construct; individual or pooled delivery if relevant.
☐ Fragment sequences	Unique IDs, exact sequences written 5′ to 3′, and total ordered lengths.
☐ Functional annotations	Coding regions, tags, linkers, regulatory elements, and other required features.
☐ Protected sequence regions	Bases that must not change and regions where redesign may be considered.
☐ Complexity flags	Local GC extremes, repeats, homopolymers, and predicted structural features.
☐ Assembly plan	Method, reagent system, number of parts, and junction or overhang sequences.
☐ Vector context	Exact backbone file, insertion coordinates, orientation, and linearization plan.
☐ Final reference	Expected assembled sequence with annotated junctions.
☐ Delivery requirements	Requested amount, concentration or dry format, packaging, and project deadline.
☐ QC expectations	Requested documentation and clarification of size, quantity, and sequence assessment.
☐ Acceptance criteria	Supplier-confirmed feasibility, approved sequence revisions, and agreed deliverable specifications.

Once these details are ready, use Dynegene’s custom gene fragment synthesis service page to discuss the project. Ask the technical team to confirm feasibility, available delivery options, QC documentation, and the quoted schedule for the submitted sequences rather than assuming these from platform-level specifications.

A practical submission package contains:

·       A FASTA file for the exact fragment sequences.

·       An annotated GenBank file for the vector or final construct, where available.

·       A spreadsheet linking fragment IDs to lengths, assembly roles, junctions, and special requirements.

These are useful preparation formats, not a claim that Dynegene accepts every format. Confirm the submission requirements before sending the order.

Make one file the authoritative source for synthesis. Annotations and spreadsheets should refer to the same sequence version. Avoid relying on screenshots, colored text, or comments to communicate bases that must be included.

Explain ambiguous bases explicitly. An “N” may mean an unresolved position or intentional sequence diversity; those requests are not equivalent. Resolve uncertainty or discuss the intended library design before approval.

Agree on what the supplier’s QC establishes and what your laboratory must verify afterward.

Size assessment and sequence assessment answer different questions.

On receipt:

1.     Match sample labels and documentation to the approved fragment IDs and sequence version.

2.     Follow the supplied handling, resuspension, and storage instructions.

3.     Check whether the documentation addresses the agreed quantity, size, and sequence requirements.

4.     After assembly, screen candidate constructs and sequence the complete inserted region and relevant junctions against the final reference.

A correctly sized band does not establish base-by-base sequence identity. Likewise, verification of an input fragment does not verify the construct produced by your subsequent assembly.

Keep the approved sequence files, supplier documentation, and final construct verification together. The strongest pre-order check is a complete chain from the intended construct to the ordered fragments, the actual vector ends, and the final verification plan—not an assumption that successful synthesis guarantees successful assembly.